Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients

Folia Neuropathologica

Volumn 48, Issue 1, 2010, Pages 45-48

  Jaśkiewicz, Ewa ^a,b   Michałowska Wender, Grazyna ^c,d   Pyszczek, Anna ^b   Wender, Mieczysław ^d  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b UNIVERSITY OF ZIELONA GÓRA   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

MBP; MOG; Multiple sclerosis; Myelin antigens; PLP

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROGLIA GLYCOPROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BLOOD; CELL ASSAY; CHO CELL; CLINICAL ARTICLE; CONFORMATION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PATIENT; RAT; RELAPSE; REMISSION;

EID: 77950843961     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Angelluci F, Mirabella M, Frisullo G, Caggiula M, Tonali PA, Batocchi AP. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy. Dis Markers 2005; 21: 49-55. (Pubitemid 40875147)
2. Garren H, Robinson WH, Krasulová E, Havrdová E, Nadj C, Selmaj K, Losy J, Nadj I, Radue EW, Kidd BA, Gianettoni J, Tersini K, Utz PJ, Valone F, Steinman L; BHT-3009 Study Group. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann Neurol 2008; 63: 611-620.
3. Greer JM, Csurhes PA, Muller DM, Pender MP. Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis. J Immunol 2008; 180: 6402-6410.
4. Holmøy T, Vartdal F. The immunological basis for treatment of multiple sclerosis. Scand J Immunol 2007; 66: 374-382. (Pubitemid 47394560)
5. Jaśkiewicz E, Jedynak A, Zioło E. Recombinant forms of myelin basic protein and proteolipid protein expressed in CHO cells. Acta Biochimica Polonica 2005; 52: 863-866. (Pubitemid 43155015)
6. Michałowska-Wender G, Wender M. Peripheral blood cell immunomarkers in the course of methylprednisolone treatment of multiple sclerosis relapses. Folia Neuropathol 2008; 46: 134-138.
7. O'Connor KC, Chitnis T, Griffin DE, Piyasirisilp S, Bar-Or A, Khoury S, Wucherpfennig KW, Hafler DA. Myelin basic proteinreactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol 2003; 136: 140-148. (Pubitemid 36298853)
8. Polman Ch, Reingold S, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846. (Pubitemid 41746873)
9. Reindl M, Khalil M, Berger T. Antibodies as biological markers for pathophysiological processes in MS. J Neuroimmunol 2006; 180: 50-62. (Pubitemid 44692320)
10. Vojdani A, Vojdani E, Cooper E. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. J Intern Med 2003; 254: 363-374. (Pubitemid 37211260)
11. Warren KG, Catz I, Johnson E, Mielke B. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann Neurol 1994; 35: 280-289. (Pubitemid 24089650)